{
  "retracted": false,
  "timestamp": 1579132800000,
  "updates": [
    {
      "timestamp": 1591728375406,
      "identifier": {
        "doi": "10.1038/s41416-019-0709-x"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41416-019-0435-4"
  },
  "journal": "British Journal of Cancer",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial"
}
